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From Headache to Heartache
Ergotamine-Induced Aortic and Mitral Valvulopathy
Sandeep M. Patel, MD,* N. Paul Ohori, MD,y Vinay Badhwar, MD,* João L. Cavalcante, MD*
Pittsburgh, Pennsylvania47-year-old female with a 10-year history of severe migraines and extensive use ofAergotamine presented with signs and symptoms of decompensated heart failure. Nohistory of rheumatic fever or childhood illness could be elicited. Transthoracic and
follow-up transesophageal echocardiogram revealed thickened leaﬂets of both mitral (A and B,
Online Video 1) and aortic (C) valves with restricted mobility and cusps doming, causing
moderate mitral stenosis (D) and severe mitral (E and F) and aortic (D) regurgitation (C and D,
Online Video 2). Severe pulmonary hypertension was noted, but there was no visible patent
foramen ovale. She underwent uneventful mechanical aortic and mitral valve replacement, and
coronary artery bypass grafting for signiﬁcant left main stenosis. Pathological analysis of her mitral
(G) and aortic (H) valvular specimens revealed tan-white, thickened tissue without calciﬁcation
that was histopathologically characterized by ﬁbrotic nodules (I) containing mucoid substance
(Alcian-blue stain, J) with surrounding elastic ﬁbers (Elastin-van Gieson stain, K and L). Findings
were consistent with ergotamine-induced valvulopathy. Echocardiographic surveillance should be
considered in those requiring long-term use of ergotamine and/or dopamine agonists.
